- Research works
- 71 ▲ 5% vs 2013–17
- Citations
- 1.8k 25.4 per fractional work
- Top-10% rate
- 16.0% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Redx Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.8×
- Medicine 2.5×
- Immunology and Microbiology 2.4×
- Nursing 2.3×
- Economics, Econometrics and Finance 1.2×
- Psychology 0.8×
- Agricultural and Biological Sciences 0.5×
- Mathematics 0.5×
- Social Sciences 0.3×
- Environmental Science 0.2×
- Computer Science 0.2×
- Neuroscience 0.2×
- Health Professions 0.2×
- Chemistry 0.1×
- Engineering 0.1×
- Materials Science 0.1×
Which keywords describe research at Redx Pharma (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Chemotherapy, Inflammation, Apoptosis, Clinical Trials, Therapeutic Targets and Medicinal Chemistry.
- p53
- Off-Label Drug Use
- Weight Loss
- Epithelial-Mesenchymal Transition
- Cancer Progression
- Drug Target Identification
- Pharmacology
- Tumor Microenvironment
- Anticancer Agents
- Topoisomerases
- Cell Signaling
- Genetic Variants
- Pharmacokinetics
- Immunotherapy
- Cell Proliferation
- Transcriptional Regulation
- Medicinal Chemistry
- Clinical Trials
- Chemotherapy
- Inflammation
- Cancer
- Cancer Therapy
- Oxidative Stress
- Apoptosis
- Therapeutic Targets
- Genomic Stability
- Epigenetic Regulation
- Metabolic Syndrome
- Arginine Methylation
- Protein Arginine Methyltransferases
- DNA
- Molecular Docking
- Insulin Resistance
- Mutation
- Androgen Receptor
- Virtual Screening
- Medication Adherence
- Fibrosis
- Cell Cycle
- Pediatric Pharmacokinetics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer7▲ 6.6×21 topics
- Inflammation5▲ 3.2×28 topics
- Cancer Therapy5▲ 10×11 topics
- Chemotherapy4▲ 8.3×8 topics
- Oxidative Stress4▲ 2.7×24 topics
- Clinical Trials3▲ 7.0×5 topics
- Apoptosis3▲ 11×9 topics
- Medicinal Chemistry3▲ 11×5 topics
- Therapeutic Targets3▲ 18×4 topics
- Transcriptional Regulation3▲ 16×7 topics
- Genomic Stability3▲ 40×2 topics
- Cell Proliferation3▲ 40×2 topics
- Epigenetic Regulation3▲ 17×3 topics
- Immunotherapy3▲ 5.6×6 topics
- Metabolic Syndrome2▲ 4.1×5 topics
- Pharmacokinetics2▲ 12×4 topics
- Arginine Methylation2▲ 91×1 topic
- Genetic Variants2▲ 14×3 topics
- Protein Arginine Methyltransferases2▲ 91×1 topic
- Cell Signaling2▲ 8.2×6 topics
- DNA2▲ 89×1 topic
- Topoisomerases2▲ 89×1 topic
- Molecular Docking2▲ 19×3 topics
- Anticancer Agents2▲ 10×3 topics
- Insulin Resistance2▲ 5.4×5 topics
- Tumor Microenvironment2▲ 7.0×6 topics
- Mutation2▲ 15×3 topics
- Pharmacology2▲ 7.1×3 topics
- Androgen Receptor2▲ 24×2 topics
- Drug Target Identification2▲ 32×1 topic
- Virtual Screening2▲ 32×1 topic
- Cancer Progression2▲ 8.9×4 topics
- Medication Adherence2▲ 36×2 topics
- Epithelial-Mesenchymal Transition1▲ 22×2 topics
- Fibrosis1▲ 9.9×2 topics
- Weight Loss1▲ 13×2 topics
- Cell Cycle1▲ 32×1 topic
- Off-Label Drug Use1▲ 50×1 topic
- Pediatric Pharmacokinetics1▲ 50×1 topic
- p531▲ 42×1 topic
Which research topics does Redx Pharma (United Kingdom) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Cancer Mechanisms and Therapy, Coagulation, Bradykinin, Polyphosphates, and Angioedema and Phosphodiesterase function and regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 2 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
- 3 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 4 Phosphodiesterase function and regulation Molecular Biology 1 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 6 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 7 Sperm and Testicular Function Reproductive Medicine 0 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 9 Pharmacology and Obesity Treatment Pharmacology 0 works
- 10 Reproductive Health and Technologies Reproductive Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Redx Pharma (United Kingdom)'s research output changed?
Output in 2018–2022 was 5% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Macclesfield
- SKA Observatory
- East Cheshire NHS Trust
- Macclesfield District General Hospital
- Macclesfield College
- Medicines Discovery Catapult
- Spire Regency Hospital
- Global Maritime Services (United Kingdom)
- Gentronix (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.